Pharma 3.0 : delivering on health outcomes
The article offers information on the latest developments which are taking place in the pharmaceutical industry in Europe. It mentions that the industry is spending time and money in reshaping the industry in terms of health care system and health facilities offered to patients. It informs that phar...
| Verfasser: | |
|---|---|
| Dokumenttypen: | Artikel |
| Medientypen: | Text |
| Erscheinungsdatum: | 2010 |
| Publikation in MIAMI: | 16.09.2010 |
| Datum der letzten Änderung: | 24.03.2023 |
| Quelle: | Journal of Business Chemistry, 7 (2010) 3, S. 155-163 |
| Angaben zur Ausgabe: | [Electronic ed.] |
| Fachgebiet (DDC): | 330: Wirtschaft |
| Lizenz: | InC 1.0 |
| Sprache: | English |
| Anmerkungen: | Section "Practicioner’s Section" |
| Format: | PDF-Dokument |
| URN: | urn:nbn:de:hbz:6-86469448955 |
| Permalink: | https://nbn-resolving.de/urn:nbn:de:hbz:6-86469448955 |
| Onlinezugriff: | 2010_vol7_iss3_155-163.pdf |
The article offers information on the latest developments which are taking place in the pharmaceutical industry in Europe. It mentions that the industry is spending time and money in reshaping the industry in terms of health care system and health facilities offered to patients. It informs that pharmaceutical companies are focusing on organizational realignment, biotechnology and personalized medicine.